‘The risk to our strategy lies in jurisdictions outside our control’
Scientists worry that variants such as the South African strain may torpedo Ireland’s attempts to get Covid under control, and even push a ‘return to normal’ into mid-2022
After battling through 2020, this was meant to be the year we escaped the pandemic, with vaccines providing the ultimate solution that would free us from restrictions and make this lockdown our last.
But as new variants emerge, scientists fear a new form of “escape” – the term used when a new variant evades immunity, rendering vaccines less effective.
The less effective vaccines are, the harder it will be to eradicate the virus by...
Subscribe from just €1 for the first month!
With any subscription you will have access to
Unlimited multi-device access to our iPad, iPhone and Android Apps
Unlimited access to our eReader library
Exclusive daily insight and opinion seven days a week
Create alerts to never miss a subject that matters to you
Get access to exclusive offers for subscribers on gifts and experiences
Get content from Business Post, Business Post Magazines, Connected, Tatler and Food & Wine
Government hopes to raise vaccination rates via passports for pubs and restaurants
Ministers hope that extending the use of vaccination passports beyond the planned date of October 22 will put pressure on more unvaccinated people to get the jab
The Last Post: Covid symptoms ‘drink-driving’ comparison is an analogy too far
Professor Philip Nolan of Nphet said ‘leaving your home with symptoms has to become socially unacceptable, like drink-driving’, but comparing people with allergies or head colds to people who drink and then get behind the wheel is over the top
Full vaccination more effective than a booster campaign, Nphet advisor says
Cathal Walsh says strain-specific top-ups can play a role but primary vaccination is still far more effective
Covid-19: Wonder drugs become another weapon in ongoing battle against the virus
Recent tests by Merck of an antiviral pill that appears to cut hospitalisation risk by 50 per cent sent the company’s shares soaring. Other companies, including Dublin-based AiPharma, are also in the race to develop antiviral medications